rs2291563

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001458.5(FLNC):​c.1458C>A​(p.Pro486Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0454 in 1,614,004 control chromosomes in the GnomAD database, including 6,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 2349 hom., cov: 33)
Exomes 𝑓: 0.038 ( 4338 hom. )

Consequence

FLNC
NM_001458.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.119
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 7-128840069-C-A is Benign according to our data. Variant chr7-128840069-C-A is described in ClinVar as [Benign]. Clinvar id is 129080.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-128840069-C-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.119 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.304 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FLNCNM_001458.5 linkuse as main transcriptc.1458C>A p.Pro486Pro synonymous_variant 9/48 ENST00000325888.13 NP_001449.3 Q14315-1Q59H94
FLNCNM_001127487.2 linkuse as main transcriptc.1458C>A p.Pro486Pro synonymous_variant 9/47 NP_001120959.1 Q14315-2Q59H94

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FLNCENST00000325888.13 linkuse as main transcriptc.1458C>A p.Pro486Pro synonymous_variant 9/481 NM_001458.5 ENSP00000327145.8 Q14315-1
FLNCENST00000346177.6 linkuse as main transcriptc.1458C>A p.Pro486Pro synonymous_variant 9/471 ENSP00000344002.6 Q14315-2

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17700
AN:
152176
Hom.:
2343
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.308
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0842
Gnomad ASJ
AF:
0.0265
Gnomad EAS
AF:
0.302
Gnomad SAS
AF:
0.0794
Gnomad FIN
AF:
0.0197
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0175
Gnomad OTH
AF:
0.0985
GnomAD3 exomes
AF:
0.0814
AC:
20301
AN:
249396
Hom.:
2190
AF XY:
0.0733
AC XY:
9923
AN XY:
135358
show subpopulations
Gnomad AFR exome
AF:
0.311
Gnomad AMR exome
AF:
0.127
Gnomad ASJ exome
AF:
0.0253
Gnomad EAS exome
AF:
0.321
Gnomad SAS exome
AF:
0.0699
Gnomad FIN exome
AF:
0.0257
Gnomad NFE exome
AF:
0.0182
Gnomad OTH exome
AF:
0.0541
GnomAD4 exome
AF:
0.0381
AC:
55618
AN:
1461710
Hom.:
4338
Cov.:
32
AF XY:
0.0378
AC XY:
27485
AN XY:
727168
show subpopulations
Gnomad4 AFR exome
AF:
0.309
Gnomad4 AMR exome
AF:
0.123
Gnomad4 ASJ exome
AF:
0.0252
Gnomad4 EAS exome
AF:
0.280
Gnomad4 SAS exome
AF:
0.0701
Gnomad4 FIN exome
AF:
0.0256
Gnomad4 NFE exome
AF:
0.0153
Gnomad4 OTH exome
AF:
0.0559
GnomAD4 genome
AF:
0.116
AC:
17732
AN:
152294
Hom.:
2349
Cov.:
33
AF XY:
0.116
AC XY:
8603
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.308
Gnomad4 AMR
AF:
0.0839
Gnomad4 ASJ
AF:
0.0265
Gnomad4 EAS
AF:
0.301
Gnomad4 SAS
AF:
0.0789
Gnomad4 FIN
AF:
0.0197
Gnomad4 NFE
AF:
0.0176
Gnomad4 OTH
AF:
0.0993
Alfa
AF:
0.0553
Hom.:
679
Bravo
AF:
0.132
Asia WGS
AF:
0.178
AC:
619
AN:
3478
EpiCase
AF:
0.0158
EpiControl
AF:
0.0163

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 10, 2023- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 12, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 15, 2013- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015p.Pro486Pro in exon 9 of FLNC: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 28.9% (1144/3952) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2291563). -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 13, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 26, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
12
DANN
Benign
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2291563; hg19: chr7-128480123; COSMIC: COSV57953400; COSMIC: COSV57953400; API